Validated HPLC‐MS/MS method for quantitation of AMG 510, a KRAS G12C inhibitor, in mouse plasma and its application to a pharmacokinetic study in mice N Madhyastha, SK Samantha, S Dittakavi, M Markose, SR Mallurwar, ... Biomedical Chromatography 35 (4), e5043, 2021 | 14 | 2021 |
LC–MS/MS-ESI method for simultaneous quantification of darolutamide and its active metabolite, ORM-15341 in mice plasma and its application to a pharmacokinetic study S Dittakavi, PKVSP Nagasuri, SP Sulochana, SM Saim, SR Mallurwar, ... Journal of Pharmaceutical and Biomedical Analysis 145, 454-461, 2017 | 14 | 2017 |
Discovery and characterization of potent pan-genotypic HCV NS5A inhibitors containing novel tricyclic central core leading to clinical candidate V Ramdas, R Talwar, M Banerjee, AA Joshi, AK Das, DS Walke, ... Journal of Medicinal Chemistry 62 (23), 10563-10582, 2019 | 13 | 2019 |
Determination of tofacitinib in mice whole blood on dried blood spots using LC–ESI–MS/MS: application to pharmacokinetic study in mice A Dixit, SR Mallurwar, SP Sulochana, M Zainuddin, R Mullangi Drug Research 69 (06), 330-336, 2019 | 11 | 2019 |
Discovery of a Potent and Selective PI3Kδ Inhibitor (S)-2,4-Diamino-6-((1-(7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenyl-4H-quinolizin-2-yl)ethyl)amino)pyrimidine-5 … MR Shukla, S Patra, M Verma, G Sadasivam, N Jana, SJ Mahangare, ... Journal of Medicinal Chemistry 63 (23), 14700-14723, 2020 | 10 | 2020 |
Discovery of isoquinolinone and naphthyridinone-based inhibitors of poly (ADP-ribose) polymerase-1 (PARP1) as anticancer agents: Structure activity relationship and preclinical … NP Karche, M Bhonde, N Sinha, G Jana, G Kukreja, SP Kurhade, ... Bioorganic & Medicinal Chemistry 28 (24), 115819, 2020 | 9 | 2020 |
Simultaneous determination of bendamustine and γ-hydroxybendamustine in mice dried blood spots and its application in a mice pharmacokinetic study NK Saini, SP Sulochana, V Kiran, SR Mallurwar, W Richter, NR Srinivas, ... Journal of Pharmaceutical and Biomedical Analysis 174, 168-174, 2019 | 7 | 2019 |
Discovery of a Novel Potent and Selective Calcium Release-Activated Calcium Channel Inhibitor: 2,6-Difluoro-N-(2′-methyl-3′-(4-methyl-5-oxo-4,5-dihydro-1,3,4 … NR Khedkar, NR Irlapatti, D Dadke, V Kanoje, Z Shaikh, V Karche, ... Journal of Medicinal Chemistry 64 (23), 17004-17030, 2021 | 6 | 2021 |
Uptake and pharmacokinetics of cefuroxime in rabbits after intravitreal, intracameral, and topical dosing: Relevance to human ocular injection of cefuroxime RK Jairam, SR Mallurwar, BB Gabani, A Zakkula, V Kiran, S Dittakavi, ... Xenobiotica 50 (3), 339-345, 2020 | 6 | 2020 |
Clinical Prospectives of Janus Kinase Inhibitors: A review SR Mallurwar, VK Nakra, MR Bhat Asian J Pharm Pharmacol 7 (2), 85-91, 2021 | 2 | 2021 |
Validated LC-ESI-MS/MS method for the determination of ivosidenib in 10 µL mice plasma: application to a pharmacokinetic study S Dittakavi, RK Jat, SR Mallurwar, RK Jairam, R Mullangi ADMET and DMPK 7 (2), 131-139, 2019 | 2 | 2019 |
Prediction of human pharmacokinetics of bendamustine from preclinical species pharmacokinetics based on normalizing time course profiles RK Jairam, SR Mallurwar, SP Sulochana, DV Chandrasekar, ... Drug Research 69 (01), 32-39, 2019 | 2 | 2019 |
Advantages of Allometric Scaling Methods for Predicting Human Pharmacokinetics of Novel JAK Inhibitor-Baricitinib and Dose Extrapolation S Mallurwar, K Daniel, M Bhat Biomedical and Pharmacology Journal 15 (1), 543-552, 2022 | 1 | 2022 |
Prediction of Human Pharmacokinetics of Fomepizole from Preclinical Species Pharmacokinetics Based on Normalizing Time Course Profiles RK Jairam, SR Mallurwar, SP Sulochana, DV Chandrasekhar, U Todmal, ... AAPS PharmSciTech 20 (6), 221, 2019 | 1 | 2019 |
MRTX-1257 N Madhyastha, SK Samantha, S Dittakavi, M Markose, SR Mallurwar, ... | | |
Comparative Analysis of Plasma and Dried Plasma Spots (DPS) of Tofacitinib-A Pan JAK inhibitor using LC-MS/MS; Application to Pharmacokinetic Study in Mice S Mallurwar, R Trivedi, M Bhat, P Jain | | |